AAAAAA

   
Results: 1-8 |
Results: 8
INTRACELLULAR EXPRESSION OF AN ANTIBODY FRAGMENT-NEUTRALIZING P21 RASPROMOTES TUMOR-REGRESSION
Authors: COCHET O KENIGSBERG M DELUMEAU I VIRONEODDOS A MULTON MC FRIDMAN WH SCHWEIGHOFFER F TEILLAUD JL TOCQUE B
Citation: O. Cochet et al., INTRACELLULAR EXPRESSION OF AN ANTIBODY FRAGMENT-NEUTRALIZING P21 RASPROMOTES TUMOR-REGRESSION, Cancer research, 58(6), 1998, pp. 1170-1176
IN-VITRO AND IN-VIVO EFFECTS OF UP-269-6, A NEW POTENT ORALLY-ACTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, ON VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION
Authors: VIRONEODDOS A DESANGLE V PROVOST D CAZES M CAUSSADE F CLOAREC A
Citation: A. Vironeoddos et al., IN-VITRO AND IN-VIVO EFFECTS OF UP-269-6, A NEW POTENT ORALLY-ACTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, ON VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION, British Journal of Pharmacology, 120(3), 1997, pp. 488-494
IN-VITRO PHARMACOLOGICAL CHARACTERIZATION OF UP-269-6, A NOVEL NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST
Authors: CAUSSADE F VIRONEODDOS A DELCHAMBRE C CAZES M VERSIGNY A CLOAREC A
Citation: F. Caussade et al., IN-VITRO PHARMACOLOGICAL CHARACTERIZATION OF UP-269-6, A NOVEL NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, Fundamental and clinical pharmacology, 9(2), 1995, pp. 119-128
SYNTHESIS AND ANGIOTENSIN-II RECEPTOR ANTAGONIST ACTIVITY OF C-LINKEDPYRIMIDINE-DERIVATIVES
Authors: NICOLAI E CURE G GOYARD J KIRCHNER M TEULON JM VERSIGNY A CAZES M VIRONEODDOS A CAUSSADE F CLOAREC A
Citation: E. Nicolai et al., SYNTHESIS AND ANGIOTENSIN-II RECEPTOR ANTAGONIST ACTIVITY OF C-LINKEDPYRIMIDINE-DERIVATIVES, European journal of medicinal chemistry, 30(5), 1995, pp. 365-375
N6-SUBSTITUTED ADENOSINE RECEPTOR AGONISTS - SYNTHESIS AND PHARMACOLOGICAL ACTIVITY AS POTENT ANTINOCICEPTIVE AGENTS
Authors: GUNGOR T MALABRE P TEULON JM CAMBORDE F MEIGNEN J HERTZ F VIRONEODDOS A CAUSSADE F CLOAREC A
Citation: T. Gungor et al., N6-SUBSTITUTED ADENOSINE RECEPTOR AGONISTS - SYNTHESIS AND PHARMACOLOGICAL ACTIVITY AS POTENT ANTINOCICEPTIVE AGENTS, Journal of medicinal chemistry, 37(25), 1994, pp. 4307-4316
SYNTHESIS AND SAR STUDIES OF NOVEL TRIAZOLOPYRIMIDINE DERIVATIVES AS POTENT, ORALLY-ACTIVE ANGIOTENSIN-II RECEPTOR ANTAGONISTS
Authors: NICOLAI E CURE G GOYARD J KIRCHNER M TEULON JM VERSIGNY A CAZES M CAUSSADE F VIRONEODDOS A CLOAREC A
Citation: E. Nicolai et al., SYNTHESIS AND SAR STUDIES OF NOVEL TRIAZOLOPYRIMIDINE DERIVATIVES AS POTENT, ORALLY-ACTIVE ANGIOTENSIN-II RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 37(15), 1994, pp. 2371-2386
SYNTHESIS AND ANGIOTENSIN-II RECEPTOR ANTAGONIST ACTIVITY OF C-LINKEDPYRAZOLE DERIVATIVES
Authors: NICOLAI E CURE G GOYARD J KIRCHNER M TEULON JM VERSIGNY A CAZES M VIRONEODDOS A CAUSSADE F CLOAREC A
Citation: E. Nicolai et al., SYNTHESIS AND ANGIOTENSIN-II RECEPTOR ANTAGONIST ACTIVITY OF C-LINKEDPYRAZOLE DERIVATIVES, Chemical and Pharmaceutical Bulletin, 42(8), 1994, pp. 1617-1630
SYNTHESIS AND ACTIVITIES OF NEW ARYLSULFONAMIDO THROMBOXANE-A(2)-RECEPTOR ANTAGONISTS
Authors: SARTORI E CAMY F TEULON JM CAUSSADE F VIRONEODDOS A CLOAREC A
Citation: E. Sartori et al., SYNTHESIS AND ACTIVITIES OF NEW ARYLSULFONAMIDO THROMBOXANE-A(2)-RECEPTOR ANTAGONISTS, European journal of medicinal chemistry, 28(7-8), 1993, pp. 625-632
Risultati: 1-8 |